← Back to Clinical Trials
Recruiting NCT05306145
Comparison of H-FIRE and TURP in Treating Benign Prostatic Hyperplasia
Trial Parameters
Condition Benign Prostatic Hyperplasia
Sponsor Shanghai East Hospital
Study Type INTERVENTIONAL
Phase N/A
Enrollment 118
Sex MALE
Min Age 40 Years
Max Age N/A
Start Date 2022-06-30
Completion 2026-01-01
Interventions
High freqnence Irreversible electroporationTrans Urethral Resection Prostate
Brief Summary
This trial is comparing the effects and safety in treating men with benign prostatic hyperplasia between high freqnence irreversible electroporation and trans urethral resection prostate.
Eligibility Criteria
Inclusion Criteria: 1. Age over 40 years old 2. IPSS\>8 3. Qmax \<15ml/s 4. Prostatic volume range of 30 to 100ml, measured by MRI 5. Fully understand the clinical trial protocol and sign the informed consent Exclusion Criteria: Have a history of prostate cancer or patients suspicious of prostate cancer Neurogenic bladder Metal implants in their body Previous history of prostatic or urethral surgery With Catheterisation more than 2 weeks Any other conditions that investigator judges that participations who are not suitable for this trial